Biomaterials in myocardial tissue engineering

J Tissue Eng Regen Med. 2016 Jan;10(1):11-28. doi: 10.1002/term.1944. Epub 2014 Jul 28.

Abstract

Cardiovascular disease is the leading cause of death in the developed world, and as such there is a pressing need for treatment options. Cardiac tissue engineering emerged from the need to develop alternative sources and methods of replacing tissue damaged by cardiovascular diseases, as the ultimate treatment option for many who suffer from end-stage heart failure is a heart transplant. In this review we focus on biomaterial approaches to augmenting injured or impaired myocardium, with specific emphasis on: the design criteria for these biomaterials; the types of scaffolds - composed of natural or synthetic biomaterials or decellularized extracellular matrix - that have been used to develop cardiac patches and tissue models; methods to vascularize scaffolds and engineered tissue; and finally, injectable biomaterials (hydrogels) designed for endogenous repair, exogenous repair or as bulking agents to maintain ventricular geometry post-infarct. The challenges facing the field and obstacles that must be overcome to develop truly clinically viable cardiac therapies are also discussed.

Keywords: biomaterials; cardiac regeneration; cardiac scaffolds; cardiac tissue engineering; cardiac tissue models; injectable hydrogels.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biocompatible Materials / pharmacology*
  • Heart / drug effects
  • Heart / physiology*
  • Humans
  • Injections
  • Myocardium / metabolism
  • Tissue Engineering / methods*
  • Tissue Scaffolds / chemistry

Substances

  • Biocompatible Materials